Home

Perceptive Life Sciences Master Fund, 10% Owner: Acrivon Therapeutics ACRV Buy · Filed 24/04/15

Trade details

Type
Insider buy
Amount
$20,000,500
Shares · price
2,353,000 sh · $8.50 a share
Held after
5,360,858 sh
Trade date
24/04/11
Filed
24/04/15
Days to filing
4 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+78.2%

Acrivon Therapeutics trades, last 26 weeks

What else happened in Acrivon Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/12~24/05/11

Perceptive Life Sciences Master Fund's recent trades